About us
Our mission: Pioneering Faster Diagnostics for Severe Infections.
Our mission is simple: Providing clinicians with actionable molecular insights when every minute counts. By eliminating the wait time of traditional cultures, we help optimize patient therapy from hour one.
<5h
Time to comprehensive, actionable syndromic testing results
100+
Patents held worldwide in advanced molecular diagnostics
CE-IVD
Fully validated and certified platform technology
Curetis at a Glance
Our Journey & Milestones
2014
International Expansion: Achieved critical regulatory milestones and aggressively expanded our global distributor footprint to support ICUs worldwide.
Today & beyond
Launching Unyvero: Successfully brought the Unyvero system to the European market, establishing our landmark Pneumonia panel in premium hospital networks.
2018
Continuously scaling our syndromic testing menu and advancing multiplex PCR technology to solve the most pressing diagnostic challenges globally.